China Resources Medical Holdings Company Limited (1PH) — Tangible Net Worth Ratio
China Resources Medical Holdings Company Limited (1PH) has a Tangible Net Worth Ratio of 99.9% as of June 2025. This metric is calculated by deducting intangible assets (€7.13 Million) from net assets (€7.77 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is China Resources Medical Holdings Company's working capital to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
China Resources Medical Holdings Company Limited Tangible Net Worth Ratio (2016–2024)
This chart shows how China Resources Medical Holdings Company Limited's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 99.9%, reflecting net assets of €7.77 Billion with intangible assets of €7.13 Million EUR. See 1PH defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for China Resources Medical Holdings Company Limited (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for China Resources Medical Holdings Company Limited from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see China Resources Medical Holdings Company (1PH) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.9% | €7.50 Billion | €7.78 Million | €13.32 Billion | ▲ +0.5 pp |
| 2023 | 99.4% | €7.01 Billion | €45.30 Million | €13.65 Billion | ▲ +0.3 pp |
| 2022 | 99.0% | €7.00 Billion | €68.66 Million | €11.10 Billion | ▲ +0.1 pp |
| 2021 | 98.9% | €6.85 Billion | €75.35 Million | €10.47 Billion | ▲ +20.1 pp |
| 2020 | 78.8% | €6.34 Billion | €1.35 Billion | €8.96 Billion | ▲ +11.9 pp |
| 2019 | 66.8% | €6.14 Billion | €2.04 Billion | €7.87 Billion | ▲ +3.5 pp |
| 2018 | 63.3% | €5.71 Billion | €2.10 Billion | €7.32 Billion | ▲ +1.0 pp |
| 2017 | 62.3% | €5.60 Billion | €2.11 Billion | €6.91 Billion | ▲ +2.1 pp |
| 2016 | 60.2% | €5.36 Billion | €2.13 Billion | €6.45 Billion | — |